Press releaseGlobe Newswire
HeartSciences
HSCSW · NASDAQ
$0.13+$0.084 (+182.61%)TodayMarket closed ·
Prev close $0.046
Latest news
- Press releaseGlobe Newswire
HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device
- Press releaseGlobe Newswire
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration
- Press releaseGlobe Newswire
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
- Press releaseGlobe Newswire
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
- Press releaseGlobe Newswire
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
- Press releaseGlobe Newswire
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.